cancer Antibody

cancer Antibody

Breast cancer

BR1008b TissueArray each 306 EUR
Description: Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM, clinical stage, and ER/PR/Her2 result, 100 cases/100 cores, replacing BR1008a

Breast cancer

BR724 TissueArray each 270 EUR
Description: Breast cancer, adjacent and adjacent normal tissue array, 66 cases/72 cores

Breast cancer

BR725 TissueArray each 270 EUR
Description: Breast cancer, adjacent and adjacent normal tissue array, 68 cases/72 cores

Colorectal cancer

CRM1501 TissueArray each 420 EUR
Description: Colorectal cancer, 150 cases.

Esophagus cancer

ES1041 TissueArray each 306 EUR
Description: Esophagus cancer, cancer adjacent and normal esophagus tissue array, including squamous cell carcinoma,adenocarcinoma,undifferentiated carcinoma, AT and normal tissue, pathology grade, TNM and clinical stage (AJCC 8.0), 104 cases/104 cores (core size 1.5mm), replacing ES1021

Lung cancer

LC751 TissueArray each 234 EUR
Description: Lung cancer, matched cancer adjacent and normal adjacent lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 25 cases/75 cores (core size 1.5mm),Recent Year Collection

Prostate cancer

PR632 TissueArray each 306 EUR
Description: Prostate cancer, hyperplasia with normal tissue array, including pathology grade, Gleason grade, Gleason score, TNM and clinical stage, 21cases/63 cores

Stomach cancer

ST1451a TissueArray each 540 EUR
Description: Stomach cancer, matched NAT, matched metastasis tissue (recent year collection samples), including pathology grade, TNM and clinical stage, 71 cases/145 cores, replacing ST1451

Human Cancer Antigen CA125 (Ovarian Cancer) Protein

abx061590-100kU Abbexa 100 kU 1446 EUR

Colon cancer and lung cancer tissue array

CLC601 TissueArray each 306 EUR
Description: Colon cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores

Stomach cancer and lung cancer tissue array

SLC601 TissueArray each 306 EUR
Description: Stomach cancer and lung cancer tissue array, including TNM and pathology grade, 60 cases/60 cores

Colon cancer with cancer adjacent tissue array

T051b TissueArray each 48 EUR
Description: Colon cancer with cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T051a

Cancer Susceptibility 3 (CASC3) Antibody

20-abx004578 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 100 ul
  • 200 ul

Cancer-Associated Nucleoprotein (CANP) Antibody

20-abx121462 Abbexa
  • 360.00 EUR
  • 526.80 EUR
  • 226.80 EUR
  • 100 ul
  • 200 ul
  • 30 ul

Cancer Susceptibility 3 (CASC3) Antibody

20-abx111351 Abbexa
  • 878.40 EUR
  • 477.60 EUR
  • 150 ul
  • 50 ul

Cancer Antigen CA19-9 Antibody

abx020532-1mg Abbexa 1 mg 1296 EUR

Cancer Antigen CA19-9 Antibody

abx020533-1mg Abbexa 1 mg 718.8 EUR

Cancer Antigen CA19-9 Antibody

abx020534-1mg Abbexa 1 mg 718.8 EUR

Cancer Antigen CA19-9 Antibody

abx020535-1mg Abbexa 1 mg 718.8 EUR

Cancer Susceptibility 3 (CASC3) Antibody

abx033281-400ul Abbexa 400 ul 627.6 EUR

Cancer Susceptibility 3 (CASC3) Antibody

abx033281-80l Abbexa 80 µl 343.2 EUR

Cancer Susceptibility 3 (CASC3) Antibody

abx025070-400ul Abbexa 400 ul 627.6 EUR

Cancer Susceptibility 3 (CASC3) Antibody

abx025070-80l Abbexa 80 µl 343.2 EUR

Cancer Susceptibility 3 (CASC3) Antibody

abx235220-100ug Abbexa 100 ug 577.2 EUR

Cancer Susceptibility 3 (CASC3) Antibody

20-abx213746 Abbexa
  • 493.20 EUR
  • 360.00 EUR
  • 100 ul
  • 50 ul

Cancer Susceptibility 3 (CASC3) Antibody

20-abx214020 Abbexa
  • 493.20 EUR
  • 360.00 EUR
  • 100 ul
  • 50 ul

Liver cancer antibody screening array

LV1001 TissueArray each 306 EUR
Description: Liver cancer antibody screening array, including TNM, clinical stage and pathology grade, 25 cases/100 cores

Kidney cancer tissue array with matched cancer adjacent and cancer kidney adjacent tissue

KD991b TissueArray each 270 EUR
Description: Kidney cancer tissue array with matched cancer adjacent and cancer kidney adjacent tissue, 33 cases/ 99 cores, replacing KD991a

Human Cancer PrimaCell15: Skin Cancer Cells Growth Medium

9-46038 CHI Scientific 5 x 100 ml Ask for price

Breast cancer with cancer adjacent breast tissue array

BC081116e TissueArray each 306 EUR
Description: Breast cancer with cancer adjacent breast tissue array, including invasive carcinoma of no special type, breast carcinoma with apocrine differentiation and AT tissue,pat hology grade, IHC (ER/PR/Her-2/Ki67) info, TNM/Stage (AJCC 7th edition), 107 cases/110 cores (core size 1.5mm), replacing BC081116d

Cervix cancer tissue array with cancer adjacent tissue

CR501a TissueArray each 234 EUR
Description: Cervix cancer tissue array with cancer adjacent tissue, including TNM, clinical stage and pathology grade, 50 cases/50 cores, replacing CR501

Pancreatic cancer tissue array with cancer adjacent tissue

PA242e TissueArray each 66 EUR
Description: Pancreatic cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing PA242d

Prostate cancer tissue array with cancer adjacent tissues

PR721 TissueArray each 306 EUR
Description: Prostate cancer tissue array with cancer adjacent tissues, including WHO grade, gleason grade, gleason score, TNM and stage info, 24 cases/72 cores

Stomach cancer with matched cancer adjacent tissue array

ST1504 TissueArray each 258 EUR
Description: Stomach cancer with matched cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 50 cases/150 cores

Breast cancer TMA

BR602 TissueArray each 270 EUR
Description: Breast cancer TMA, 3 samples have matched cancer adjacent tissue samples, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 57 cases/60 cores (Core Size 1.5mm), recent tear collections

Kidney cancer (CCRCC

KD1201 TissueArray each 306 EUR
Description: Kidney cancer (CCRCC,PRCC,CRCC)with kidney tissue array,including ISUP Grade, TNM/Stage, 120 cases/120 cores (core size 1.0mm ), (Previous Item# is BC07115b)

Small intestine cancer

SM208 TissueArray each 546 EUR
Description: Small intestine cancer, metastatic lymph nodes and normal tissue high density tissue microarray, 69 cases/208 core, with stage and grade data

Cancer/testis Antigen 2 (CTAG2) Antibody

20-abx149592 Abbexa
  • 510.00 EUR
  • 410.40 EUR
  • 100 ug
  • 50 ug

Cancer/Testis Antigen 1B (CTAG1B) Antibody

20-abx171540 Abbexa
  • 1028.40 EUR
  • 526.80 EUR
  • 1 mg
  • 200 ug

Cancer/Testis Antigen 1B (CTAG1B) Antibody

20-abx135754 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 218.40 EUR
  • 376.80 EUR
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx145140-100ug Abbexa 100 ug 469.2 EUR

Oral Cancer Overexpressed 1 (ORAOV1) Antibody

20-abx007927 Abbexa
  • 360.00 EUR
  • 526.80 EUR
  • 226.80 EUR
  • 100 ul
  • 200 ul
  • 30 ul

Bladder Cancer-Associated Protein (BLCAP) Antibody

20-abx119060 Abbexa
  • 376.80 EUR
  • 117.60 EUR
  • 477.60 EUR
  • 594.00 EUR
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Cancer/Testis Antigen 1A (CTAG1A) Antibody

20-abx126874 Abbexa
  • 493.20 EUR
  • 710.40 EUR
  • 100 ul
  • 200 ul

Cancer/Testis Antigen 1B (CTAG1B) Antibody

20-abx128209 Abbexa
  • 510.00 EUR
  • 159.60 EUR
  • 1446.00 EUR
  • 693.60 EUR
  • 393.60 EUR
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Cancer/Testis Antigen 1A (CTAG1A) Antibody

20-abx111352 Abbexa
  • 878.40 EUR
  • 477.60 EUR
  • 150 ul
  • 50 ul

Oral Cancer Overexpressed 1 (ORAOV1) Antibody

20-abx013722 Abbexa
  • 376.80 EUR
  • 117.60 EUR
  • 477.60 EUR
  • 594.00 EUR
  • 100 ug
  • 10 ug
  • 200 ug
  • 300 µg

Cancer Antigen CA 19-9 Antibody

abx023798-1mg Abbexa 1 mg 1053.6 EUR

Cancer/Testis Antigen 1A (CTAG1A) Antibody

abx027441-400ul Abbexa 400 ul 627.6 EUR

Cancer/Testis Antigen 1A (CTAG1A) Antibody

abx027441-80l Abbexa 80 µl 343.2 EUR

Cancer/testis Antigen 2 (CTAG2) Antibody

abx027593-400ul Abbexa 400 ul 627.6 EUR

Cancer/testis Antigen 2 (CTAG2) Antibody

abx027593-80l Abbexa 80 µl 343.2 EUR

Oral Cancer Overexpressed 1 (ORAOV1) Antibody

abx331088-100ul Abbexa 100 ul 510 EUR

Cancer/Testis Antigen 1A (CTAG1A) Antibody

abx331930-100ul Abbexa 100 ul 510 EUR

Cancer/Testis Antigen 5.1 (SSX1) Antibody

20-abx302290 Abbexa
  • 493.20 EUR
  • 2214.00 EUR
  • 718.80 EUR
  • 218.40 EUR
  • 360.00 EUR
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cancer/Testis Antigen 5.1 (SSX1) Antibody

20-abx323587 Abbexa
  • 376.80 EUR
  • 292.80 EUR
  • 100 ug
  • 50 ug

Oral Cancer Overexpressed 1 (ORAOV1) Antibody

20-abx324804 Abbexa
  • 376.80 EUR
  • 292.80 EUR
  • 100 ug
  • 50 ug

Bladder Cancer-Associated Protein (BLCAP) Antibody

20-abx326375 Abbexa
  • 376.80 EUR
  • 292.80 EUR
  • 100 ug
  • 50 ug

Cancer/Testis Antigen 5.1 (SSX1) Antibody

abx238257-100ug Abbexa 100 ug 661.2 EUR

Urinary Bladder Cancer Antigen (UBC) Antibody

abx239152-100ug Abbexa 100 ug 610.8 EUR

Anti-Breast Cancer Resistance Protein antibody

STJ16100903 St John's Laboratory 1 mL 573.6 EUR

Anti-Breast Cancer Resistance Protein antibody

STJ16100916 St John's Laboratory 1 mL 573.6 EUR

AMACR / p504S Antibody (Prostate Cancer Marker)

R32468 NSJ Bioreagents 100 ug 419 EUR

AMACR / p504S Antibody (Prostate Cancer Marker)

V8435-100UG NSJ Bioreagents 100 ug 499 EUR
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

AMACR / p504S Antibody (Prostate Cancer Marker)

V8435-20UG NSJ Bioreagents 20 ug 219 EUR
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

AMACR / p504S Antibody (Prostate Cancer Marker)

V8435SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

AMACR / p504S Antibody (Prostate Cancer Marker)

V8645-100UG NSJ Bioreagents 100 ug 499 EUR
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

AMACR / p504S Antibody (Prostate Cancer Marker)

V8645-20UG NSJ Bioreagents 20 ug 219 EUR
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

AMACR / p504S Antibody (Prostate Cancer Marker)

V8645SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: This antibody recognizes a protein of 42kDa, which is identified as AMACR, also known as p504S. It is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

AMACR / p504S Antibody (Prostate Cancer Marker)

V8877-100UG NSJ Bioreagents 100ug 499 EUR
Description: AMACR, also known as p504S, is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

AMACR / p504S Antibody (Prostate Cancer Marker)

V8877-20UG NSJ Bioreagents 20ug 219 EUR
Description: AMACR, also known as p504S, is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.

AMACR / p504S Antibody (Prostate Cancer Marker)

V8877SAF-100UG NSJ Bioreagents 100ug 499 EUR
Description: AMACR, also known as p504S, is an enzyme that is involved in bile acid biosynthesis and -oxidation of branched-chain fatty acids. AMACR is essential in lipid metabolism. It is expressed in cells of premalignant high-grade prostatic intraepithelial neoplasia (HGPIN) and prostate adenocarcinoma. The majority of the carcinoma cells show a distinct granular cytoplasmic staining reaction. AMACR is present at low or undetectable levels in glandular epithelial cells of normal prostate and benign prostatic hyperplasia. A spotty granular cytoplasmic staining is seen in a few cells of the benign glands. AMACR is expressed in normal liver (hepatocytes), kidney (tubular epithelial cells) and gall bladder (epithelial cells). Expression has also been found in lung (bronchial epithelial cells) and colon (colonic surface epithelium). AMACR expression can also be found in hepatocellular carcinoma and kidney carcinoma. Past studies have also shown that AMACR is expressed in various colon carcinomas (well, moderately and poorly differentiated) and over expressed in prostate carcinoma.